EGFR/IGF1R Signaling Modulates Relaxation in Hypertrophic Cardiomyopathy
2023 · Circulation Research · 19 citations
https://doi.org/10.1161/circresaha.122.322133
R
Richard de Goeij-de Haas
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
62
Papers
1.1K
Citations
11
h-index
11
i10-index
Richard de Goeij-de Haas is an academic researcher from Vrije Universiteit Amsterdam. The author has contributed to research in topics: Colorectal Cancer Treatments and Studies & Pancreatic and Hepatic Oncology Research & Lung Cancer Treatments and Mutations. The author has an h-index of 11, co-authored 53 publications.
ORCID: 0000-0003-3389-375XPapers by this author
worksNon-thermal plasma as promising anti-cancer therapy against bladder cancer by inducing DNA damage and cell cycle arrest
2025 · Scientific Reports · 7 citations
https://doi.org/10.1038/s41598-025-85568-0
Candidate biomarkers for treatment benefit from sunitinib in patients with advanced renal cell carcinoma using mass spectrometry-based (phospho)proteomics
2023 · Clinical Proteomics · 2 citations
https://doi.org/10.1186/s12014-023-09437-6
Phosphoproteomics of Hypertrophic Cardiomyopathy Patient Myocardium and Novel hiPSC-CM Model Reveal Protein Kinase A as a Modulator of Microtubule Repolymerization
2026 · bioRxiv (Cold Spring Harbor Laboratory) · 0 citations
https://doi.org/10.64898/2026.02.18.706710
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat